Inhibition of extrapyramidal side effects of haloperidol through the joint use of imipramine-type drugs.
D000293:Adolescent; D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000517:prevention & control*; D003891:Desipramine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*
D006220:Haloperidol; D007099:Imipramine; D003891:Desipramine